Allergy Asthma Associates

Europrevall

|

|

|

The different trials conducted/ongoing at the centre are listed in the table below.

Global Trials

Study Titles	Sponsor	Subject Allotted	Time Allotted	Recruitment Time	Patient Enrollment Details
					Screened	Randomized	Completed
Effect of (PDE inhibitor)Phase 3	Altana	20	12 months	1months	30	19	12

National Trials

Study Titles	Sponsor	Subject Allotted	Time Allotted	Recruitment Time	Patient Enrollment Details
Study Titles	Sponsor	Subject Allotted	Time Allotted	Recruitment Time	Screened	Randomized	Completed
*RBX 7796* Phase 2	Ranbaxy	36	8 months	6 months	86	58	55
*Tiotropium* Phase 3	Ranbaxy	10	3 months	1&1/2 months	28	22	20
*Ciclesonide* Phase 3	Ranbaxy	20	6 months	5 months	69	55	55
Formoterol CFC vs HFA Phase 3	Cipla (Clintec)	80	8 months	3 months	88	80	74
*Formoterol* Fluticasone Phase 3	Ranbaxy	20	6 weeks	2 weeks	22	20	20
*Seroflo* CFC vs HFA Phase 3	Cipla (Omnicare)	80	3 months	1&1/2 months	85	69	69
*Multihaler* Phase 4	Cipla	40	2 months	1&1/2 months	40	35	35
(ICS+LABA) Phase 4	Cipla	35	2 months	3 weeks	50	35	Ongoing